Coya Therapeutics Reports Additional Proof-of-Concept Clinical Biomarker Data in Patients with Alzheimers Disease

COYA Stock   6.23  0.11  1.80%   
About 55% of Coya Therapeutics,'s investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Coya Therapeutics, Common suggests that some traders are interested. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
  
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing multiple therapeutic platforms int

Read at businesswire.com
businesswire News
  

Coya Therapeutics, Fundamental Analysis

We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

Coya Therapeutics, is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Coya Therapeutics, Common Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.

Peers

Coya Therapeutics, Related Equities

INABIn8bio   9.68   
0%
100.0%
CGTXCognition Therapeutics   9.52   
0%
98.0%
INZYInozyme Pharma   5.84   
0%
60.0%
LTRNLantern Pharma   4.27   
0%
44.0%
ABOSAcumen Pharmaceuticals   4.17   
0%
43.0%
CUECue Biopharma   3.64   
0%
37.0%
TCRXTscan Therapeutics   3.34   
0%
34.0%
HLVXHillevax   2.49   
0%
25.0%
GANXGain Therapeutics   2.23   
0%
23.0%
DAWNDay One   2.15   
0%
22.0%
NAMSWNewAmsterdam Pharma   1.21   
0%
12.0%
TERNTerns Pharmaceuticals   0.46   
0%
4.0%
STROSutro Biopharma   1.06   
10.0%
0%
OPTOpthea   1.62   
16.0%
0%
FENCFennec Pharmaceuticals   1.78   
18.0%
0%
ELYMEliem Therapeutics   1.90   
19.0%
0%
CNTACentessa Pharmaceuticals   3.27   
33.0%
0%
TFFPTff Pharmaceuticals   3.45   
35.0%
0%
DRMADermata Therapeutics   7.64   
78.0%
0%

Complementary Tools for Coya Stock analysis

When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account